Health Strategies Group Key Finding #1 1/15/2019 Health Strategies Group Author/Artist Evolving Market Dynamics Will Influence Stakeholders to Selectively Limit Access to Branded ARVs by 2019 Availability of new brands and entrance of additional multisource generics may compel some stakeholders to intensify management tactics. Biopharmaceutical companies that support stakeholder objectives of achieving high-quality, cost-effective long-term care for HIV patients will benefit from improved relationships and likely sustain optimal access for their brands. To request slides info@healthstrategies.com